The University of Birmingham and Acticor Biotech announce
University of Birmingham and Acticor Biotech News ReleaseLimited clinical access available The University of Birmingham and Acticor Biotech announce...
Source: globenewswire.com
📰 Jon Townend News
Jon Townend News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jon Townend. Real-time updates on events, politics, business and more.
University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study
September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.
United Kingdom Jon Townend Mark Thomas Lily Ramsey University Of Birmingham Consultant Cardiologist At University Hospitals Birmingham
Source: news-medical.net
World's first clinical trial to test new drug glenzocimab for heart attacks
A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing of a partnership between the University of Birmingham and Acticor Biotech, a new clinical trial called LIBERATE will take place in two acute care hospitals in the UK: the Queen Elizabeth ...
United Kingdom Mark Thomas Gilles Avenard Jon Townend Institute Of Cardiovascular Sciences Consultant Cardiologist At University Hospitals Birmingham
Source: pharmiweb.com
Acticor Biotech starts trial for heart attack drug Glenzocimab
Acticor Biotech's glenzocimab, a potential new drug to improve the long-term outcomes for heart attack patients will be trialed in the U.K.
Mark Thomas Gilles Avenard Jon Townend Institute Of Cardiovascular Sciences University Of Birmingham University Hospitals Birmingham
Source: labiotech.eu
First clinical trial to test novel heart attack drug
The first clinical trial for new heart attack drug glenzocimab, will evaluate its ability to reduce heart damage following a heart attack.
Mark Thomas Gilles Avenard Jon Townend Institute Of Cardiovascular Sciences Consultant Cardiologist At University Hospitals Birmingham University Of Birmingham
Source: europeanpharmaceuticalreview.com
Acticor Biotech: World's First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks
Regulatory News: Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug
Source: finanznachrichten.de